XML 15 R3.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Profit or loss [abstract]    
Revenue (Note 13) $ 41,459 $ 32,055
Cost of revenue (Note 14 and 15) 8,054 6,552
Gross profit 33,405 25,503
Operating expenses    
General and administrative (Note 15) 7,556 7,375
Sales and marketing (Note 15) 16,772 13,747
Research and development (Note 15) 7,377 6,186
Share-based compensation (Note 11) 1,267 1,094
Foreign exchange loss 102 3,391
Depreciation and amortization (Note 5, 6 and 7) 707 580
Operating expenses 33,781 32,373
Operating loss (376) (6,870)
Finance income, net (Note 9) (2,167) (19)
Other expense (income), net 183 (21)
Income (loss) before income taxes 1,608 (6,830)
Income tax expense 363 129
Net income (loss) for the periods 1,245 (6,959)
Item that may be reclassified subsequently to income:    
Exchange gain on translation of foreign operations (159) (3,212)
Comprehensive income (loss) $ 1,404 $ (3,747)
Income (loss) per share - basic (in USD per share) $ 0.04 $ (0.21)
Income (loss) per share - diluted (in USD per share) $ 0.04 $ (0.21)
Weighted average number of common shares outstanding - basic (Note 13) (in shares) 33,153,231 33,017,421
Weighted average number of common shares outstanding - diluted (Note 13) (in shares) 34,159,651 33,017,421